key: cord-0755608-lk8qfh90 authors: None, H.; Zhang, X.; Li, X.; Li, D. title: Circulating cytokines and lymphocyte subsets in patients who have recovered from COVID-19 date: 2020-07-24 journal: nan DOI: 10.1101/2020.07.22.20160259 sha: c9bf493dbfe5c64dcbcfe5751637a9a4cf62a653 doc_id: 755608 cord_uid: lk8qfh90 To investigate the immune status of people who previously had COVID-19 infections, we recruited patients 2 weeks post-recovery and analyzed circulating cytokines and lymphocyte subsets. We measured levels of total lymphocytes, CD4+ T cells, CD8+ T cells, CD19+ B cells, CD56+ NK cells, and the serum concentrations of interleukin (IL)-1, IL-4, IL-6, IL-8, IL-10, transforming growth factor beta (TGF-{beta}), tumor necrosis factor alpha (TNF-), and interferon gamma (IFN-{gamma}) by flow cytometry. We found that in most post-recovery patients, levels of total lymphocytes (66.67%), CD3+ T cells (54.55%), CD4+ T cells (54.55%), CD8 + T cells (81.82%), CD19+ B cells (69.70%), and CD56+ NK cells(51.52%) remained lower than normal, whereas most patients showed normal levels of IL-2 (100%), IL-4 (80.88%), IL-6 (79.41%), IL-10 (98.53%), TNF- (89.71%), IFN-{gamma} (100%) and IL-17 (97.06%). Compared to healthy controls, 2-week post-recovery patients had significantly lower absolute numbers of total lymphocytes, CD3+ T cells, CD4+ T cells, CD8+ T cells, CD19+ B cells, and CD56+ NK cells, along with significantly higher levels of IL-2, IL-4, IL-6, IL-10, TNF-, IFN-{gamma} and IL-17. Among post-recovery patients, T cells, particularly CD4+ T cells, were positively correlated with CD19+ B cell counts. Additionally, CD8+ T cells positively correlated with CD4+ T cells and IL-2 levels, and IL-6 positively correlated with TNF- and IFN-{gamma}. These correlations were not observed in healthy controls. By ROC curve analysis, post-recovery decreases in lymphocyte subsets and increases in cytokines were identified as independent predictors of rehabilitation efficacy. These findings indicate that the immune system has gradually recovered following COVID-19 infection; however, the sustained hyper-inflammatory response for more than 14 days suggests a need to continue medical observation following discharge from the hospital. Longitudinal studies of a larger cohort of recovered patients are needed to fully understand the consequences of the infection. were vortexed and incubated at room temperature for 20 min in the dark. Next, 1 mL of lysing solution was added to all tubes. After incubating tubes at room temperature for an additional 20 min in the dark, samples were centrifuged at 200 x g in a low-speed centrifuge for 5 min, then supernatant was aspirated, and 2 mL of PBS were added to each tube. Samples were centrifuged again at 200 x g for 5 min, supernatant was aspirated, and 500 μL of PBS were added. The samples were then analyzed by fluorescence-labeled flow cytometry on a DxFLEX flow cytometer (Beckman Coulter). containing separating gel and centrifuged at 2000-4000rpm for 20 min to obtain serum for analysis. Seven cytokines including IL-2, IL-4, IL-6, IL-10, IL-17, TNF-α, and IFN-γ were detected by multiple microsphere flow immunofluorescence according to the manufacturer's instructions. After blood samples and the corresponding flow tube were numbered from 1 to 27, the captured microsphere mixture was centrifuged at 200 x g in a low-speed centrifuge for 5 min, and supernatant was carefully aspirated. Microsphere buffer of the same volume as the supernatant was then added, and samples were mixed on a whirlpool well then incubated in the dark for 30 min. Next, 25 μL of the above incubated captured microsphere mixture, 25 μL of centrifuged serum, and 25 μL of fluorescent reagents were added to the corresponding flow tube, and all . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 24, 2020. . https://doi.org/10.1101/2020.07.22.20160259 doi: medRxiv preprint tubes were mixed well. After incubating at room temperature for 2.5 hours in the dark, 1 mL of PBS was added into each flow tube. After centrifuging at 200 x g for 5 min, the supernatant was carefully aspirated, and 100 μL of PBS were added to each flow tube. Fluorescent detection was then performed on a calibrated flow cytometer for each sample in sequence. 2.6. Statistics. All statistical analyses were performed using EXCEL (Microsoft) and SPSS Statistics version 21.0 software. Briefly, the data were inspected using scatter and distribution plots, outliers were removed following Dixon's rule, and normality was determined using the Shapiro-Wilk test. Continuous variables were expressed as x ± s, and the comparison between groups was analyzed by t-tests. Non-continuous variables were expressed as median with interquartile range (IQR), and the comparison between groups was analyzed using nonparametric comparative tests. Correlation analysis results were expressed by Pearson or Spearman correlation coefficient, with a larger r indicating a stronger linear correlation. P<0.05 was considered as statistically significant. after recovering from COVID-19 (48 males and 20 females) with a mean age of 33.98 ± 8.03 (21-66) years-old, and 28 healthy controls (8 males and 20 females) with a mean age of 35.13 ± 8.85 (21-49) years-old. Due to the impact of the epidemic during the early stages of this study, it should be noted that the supply of reagents was insufficient. Thus, samples from only 33 of 68 post-recovery patients were analyzed. According to the results of each measurement, CD4 + T cells, CD8 + T cells, CD19 + B cells, CD56 + NK cells and CD4 + / CD8 + T cells were divided into below normal range, within normal range and above normal range. The corresponding quantification of each lymphocyte subset, and proportions in each of the aforementioned ranges, were calculated, with the results shown in Table 1 . Among the 33 post-recovery patients, 22 (66.67%) patients had total lymphocyte counts below the normal range, 9 (27.27%) patients were within the normal range, and 2 (6.06%) patients were above the normal range. 18 (54.55%) patients had CD3 + T cell counts below the normal range, 12 (36.36%) patients were within the normal range, and 3 (9.09%) patients were above the normal range. 18 (54.55%) patients had CD4 + T cell counts below the normal range, 13 (39.39%) patients were within the normal range, and 2 (6.06%) patients were above the normal range. 27 (81.82%) patients had CD8 + T cell counts below the normal range, 5 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 24, 2020. . https://doi.org/10.1101/2020.07.22.20160259 doi: medRxiv preprint (15.15%) patients were within the normal range, and 1 (3.03%) patient was above the normal range. 23 (69.70%) patients had CD19 + B cell counts below the normal range, 9 (27.27%) patients were within the normal range, and 1 (3.03%) patient was above the normal range. 17 (51.52%) patients had CD56 + NK cell counts below the normal range, and 16 (48.48%) patients were within the normal range. 29 (87.88%) patients had CD4 + /CD8 + cell ratios within the normal range, and 4 (12.12%) patients were above the range. Among the 28 healthy controls, 5 (17.86%) patients had total lymphocyte counts below the normal range, 18 (64.28%) patients were within the normal range，and 5 (17.86%) patients were above the normal range. 5 (17.86%) patients had CD3 + T cell counts below the normal range, 19 (67.86%) patients were within the normal range, and 4 (14.28%) patients were above the normal range. 5 (17.86%) patients had CD4 + T cell counts below the normal range, and 23 (82.14%) patients were within the normal range. 4 (14.29%) patients had CD8 + T cell counts below the normal range, 17 (60.71%) patients were within the normal range, and 7 (25%) patients were above the normal range. 15 (53.57%) patients had CD19 + B cell counts below the normal range, 12 (42.86%) patients were within the normal range, and 1 (3.57%) patient was above the normal range. 7 (25%) patients had CD56 + NK cell counts below the normal range, 17 (60.71%) patients were within the normal range, and 4 (14.29%) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 24, 2020. . https://doi.org/10.1101/2020.07.22.20160259 doi: medRxiv preprint patients were above the normal range. 27 (96.43%) patients had CD4 + /CD8 + cell ratios within the normal range, and 1 (3.57%) patient was above normal. Interestingly, there were significant differences in the levels of total lymphocytes, CD3 + T cells, CD4 + T cells, CD8 + T cells, CD19 + B cells, CD56 + NK cells, IL-2, . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 24, 2020. . https://doi.org/10.1101/2020.07.22.20160259 doi: medRxiv preprint IL-4, IL-6, IL-10, TNF-α, IFN-γ and IL-17, while the CD4 + /CD8 + ratio showed no significant differences between post-recovery patients and healthy controls (P < 0.05). These results are shown in Table 3 and Figure 1 . Considering that we observed significant differences in cytokines and lymphocyte subsets between patients who recovered from COVID-19 and healthy controls, the correlations between the cytokines and lymphocyte subsets were analyzed. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 24, 2020. inducing the production of a large number of Th17-related cytokines, which can further lead to dysfunction of the innate and adaptive immune systems [9] . It has been also shown that targeting the microenvironment and epigenome of the infected organism to regulate relevant immune pathways are effective strategies to treat coronavirus infections [10, 11, 12, 13] . However, the lack of knowledge regarding the impact of COVID-19 on the immune system remains a critical issue due to its rapid spread and the shortage of specific therapies [14] . In this study we characterized lymphocyte subsets and cytokines in the peripheral blood of patients 2 weeks after recovering from COVID-19 infections. Our observed results may explain why some patients fell sick after being discharged; thus, we suggest that the current criteria for hospital discharge should be re-evaluated. Lymphocytes play critical roles in viral clearance during respiratory infections. Previous studies indicated that SARS-CoV-2 infections could lead to dysregulation of the levels of lymphocyte subsets, by showing that the absolute counts of CD3 + T cells, CD4 + T cells, CD8 + T cells, CD19 + B cells, and CD56 + NK cells were reduced in patients with COVID-19 [2, 5] . This suggests that the coronavirus may consume many immune cells, thereby inhibiting the body's cellular immunity. Moreover, with disease . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 24, 2020. . https://doi.org/10.1101/2020.07.22.20160259 doi: medRxiv preprint improvement, the levels of total lymphocytes, CD8 + T cells and B cells increased [5] . In our study, we found that in 33 post-recovery patients, most of them still exhibited lower than normal levels of total lymphocytes, total T cells, CD4 + T cells, CD8 + T cells, B cells, and NK cells. This is consistent with the results reported by Wen et al., which revealed that NK and T cells decreased in the peripheral blood of COVID-19 patients in both the early and late recovery stages [15] . Their study also demonstrated that cell-to-cell interactions may contribute to T cells and B cells, which may explain why the frequencies of peripheral blood lymphocytes gradually increased in recovering patients. In our study, compared to healthy controls, post-recovery patients displayed significantly lower absolute numbers of total lymphocytes, total T cells, CD4 + T cells, CD8 + T cells, B cells, and NK cells. This was also consistent with the above mentioned study by Wen et al. [15] , which found that compared to healthy controls, the absolute number of CD8 + T cells, NK cells and CD4 + T cells decreased in COVID-19 patients, especially in the recovery stage; however they observed no significant changes in CD19 + B cell counts, unlike in our study. Possible reasons for this discrepancy may be the direct infection of lymphocytes by SARS-CoV2, cytokine-mediated lymphocyte trafficking into infected tissues, or lymphocyte exhaustion in the peripheral blood. There may also be immune-mediated lymphocyte destruction as reported in other viral . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 24, 2020. . https://doi.org/10.1101/2020.07.22.20160259 doi: medRxiv preprint infections [15] . These potential hypotheses require further investigation. Since peripheral lymphocytes decrease following after clinical cure and discharge, it is necessary to continue to observe and follow-up with COVID-19 patients to understand the long-term effects of SARS-CoV2 on immune functions. In addition, due to the lack of clinical data in the early advanced stages of the disease, the alterations and functions of lymphocytes, particularly B cells, throughout the course of the disease need further study. Previous studies have indicated that cytokine storms play an important role in severe COVID-19 cases [5, 6] . SARS-CoV-2 binds to alveolar epithelial cells, then the virus activates the innate and adaptive immune systems, resulting in the release of a large number of cytokines. In our study, we found that in 33 post-recovery patients, most of them showed normal levels of IL-2, IL-4, IL-6, IL-10, TNF-α, IFN-γ, and IL-17. However, compared to healthy controls, patients who recovered from COVID-19 displayed significantly higher levels of IL-2, IL-4, IL-6, IL-10, TNF-α, IFN-γ and IL-17. These results suggest that SARS-CoV-2 infection, patients who recover will improve their antiviral ability within a certain period of time, then show a relatively active state of immunity. These alterations in cytokines were also found in the pneumonia caused by SARS-CoV-1. In a study by Fan et al., stimulation of peripheral blood mononuclear cells from patients 4 years after recovering from . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 24, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 24, 2020. There are some limitations in this study. Firstly, due to the lack of clinical data during the early infection stage, continuous observational data from the same cases are absent, and potential influence by early events are not considered. Secondly, the sample size was relatively small in comparison with Wuhan where the disease originated, which may have some impact on the statistical results. In future experiments, we will conduct follow-up studies in the patients who recovered from COVID-19, and determine a quantitative basis for intervention of rehabilitation measures. This will help treat the diseases at an earlier stage by promoting medical intervention in a timely manner. Moreover, it may be beneficial to analyze if a particular population has an added immunological advantage while combating the virus. In the present study, we applied flow cytometry to comprehensively characterize changes in circulating lymphocyte subsets and cytokines in patients who have recovered from COVID-19, as an assessment of their immune status following discharge. The results of both lymphocyte subsets and cytokines indicated that the immune system gradually recovers; however, the sustained hyper-inflammatory response lasting more than 14 days following discharge suggests the need for continued medical observation after patients are discharged from the hospital. Longitudinal studies of recovered patients in a larger cohort might help to . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 24, 2020. . https://doi.org/10.1101/2020.07.22.20160259 doi: medRxiv preprint better understand the consequences of the disease. The data are stored in the laboratory database. The authors declare that there are no conflicts of interest regarding the publication of this paper. vol. 395, no. 10223, pp. 497-506, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 24, 2020. . Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality Interpretation of 'Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia A novel coronavirus from patients with pneumonia in China To sense or not to sense viral RNA-essentials of coronavirus innate immune evasion Epigenetic landscape during coronavirus infection SARS-CoV-encoded small RNAs contribute to infection-associated lung pathology The NF-κB-dependent and -independent transcriptome and chromatin landscapes of human coronavirus 229E-infected cells Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing Phenotypic classification of human CD4+ T cell subsets and their differentiation This work was financially supported by Shanxi Province Social Development Program (No. 202003D31014/GZ).